Latest News Archive
Please select Category, Year, and then Month to display items
16 March 2021
|
Story Lacea Loader
![]()
All academic activities have been suspended on all UFS campuses from 17 to 22 March 2021. No online/face-to-face lectures/tests/assignments will take place until 23 March 2021, and the full academic programme will resume on this date.
This decision will allow the university management an opportunity to address outstanding matters regarding the admission of senior undergraduate students.
Administrative activities will continue during this time and the campuses are not closed. The university management is aware that sporadic disruptions of activities by small groups are still taking place on the Bloemfontein Campus.
Protection Services, with the assistance of private security, remains on high alert and is closely monitoring the situation on the campuses. The necessary safety and security plan, as well as contingency plans, are in place.
Please monitor the university’s communication platforms for updates on any developments.
It is important to ensure that your cellphone number is updated in order to receive communication via the KovsieApp and SMS.
Released by:
Lacea Loader (Director: Communication and Marketing)
Telephone: +27 51 401 2584 | +27 83 645 2454
Email: news@ufs.ac.za | loaderl@ufs.ac.za
Fax: +27 51 444 6393
Otorhinolaryngology research hopes to decrease morbidity
2016-10-04
Prof Riaz Seedat, Head of the
Department of
Otorhinolaryngology at the UFS
Prof Riaz Seedat, Head of the Department of Otorhinolaryngology at the UFS is a world-renowned ear, nose and throat specialist and researcher. He is also a National Research Foundation C3 rated scientist.
He is conducting his research in ear, nose and throat (ENT) pathology in a developing world setting, particularly focusing on recurrent respiratory papillomatosis and other ENT conditions. “This condition is caused by human papillomavirus (HPV), infective conditions as well as allergic rhinitis,” said Prof Seedat.
Current research is aimed at further describing the epidemiology of recurrent respiratory papillomatosis, identification of the HPV variants responsible for causing the condition and markers of disease aggressiveness.
The research has led to various international partnerships such as the multicentre collaborative studies, “Genetic Susceptibility to Papilloma-induced Voice Disturbance” at the Centre for Genomic Sciences at the Allegheny-Singer Research Institute in Pittsburgh, United States, and the HPV6/11 Global Diversity Consortium at the University of Ljubljana in Slovenia.
Although most head and neck squamous cell carcinomas are caused by excessive tobacco and alcohol use, there is an increasing body of evidence to show that HPV causes a subset of head and neck squamous cell carcinomas. However, there are few studies on the role of HPV in head and neck neoplasms in developing countries.
“Through the research we have shown that recurrent respiratory papillomatosis, caused by HPV, is not as rare in South Africa as it is in developed countries and that patients usually present respiratory papillomatosis at an advanced stage when the condition is life-threatening,” said Prof Seedat.
“It is hoped that this research will help us to address the morbidity caused by ENT conditions common in developing countries,” said Prof Seedat.